Skip to main content
SpringerLink
Log in

Euthyroid hyperthyroxinemia

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Robbins J., Rail J.E. II. Hormone transport in circulation: interaction of thyroid hormones and proteins in biological fluids. Rec. Progr. Horm. Res. 13. 161, 1957.

    PubMed  CAS  Google Scholar 

  2. Oppenheimer J.H. Role of plasma proteins in the binding, distribution and metabolism of thyroid hormones. N. Engl. J. Med. 278:1153, 1968.

    PubMed  CAS  Google Scholar 

  3. Robbins J., Cheng S., Gershengorn M.C., Glinoer D., Cahmann H.J. Edelhoch H. Thyroxine transport proteins of plasma, molecular properties and biosynthesis. Rec. Progr. Horm. Res. 34: 477, 1978.

    PubMed  CAS  Google Scholar 

  4. Dos Remedios L.V., Weber P.M., Feldman R., Schurr D.A., Tsoi T.G. Detecting unsuspected thyroid dysfunction by the free thyroxine index. Arch. Intern. Med. 140: 1045, 1980.

    PubMed  CAS  Google Scholar 

  5. Woeber K.A., Ingbar S.H. The contribution of thyroxine-binding pralbumin to the binding of thyroxine in human serum, as assessed by immunoadsorption. J. Clin. Invest. 47: 1710, 1968.

    PubMed Central  PubMed  CAS  Google Scholar 

  6. Dowling J.T., Freinkel N., Ingbar S.H. Effect of diethylstibestrol on binding of thyroxine in serum. J. Clin. Endocrinol. Metab., 16: 1491, 1956.

    PubMed  CAS  Google Scholar 

  7. Robbins J., Nelson J.H. Thyroxine binding by serum protein in pregnancy and in the newborn. J.Clin. Invest. 37: 153, 1958.

    PubMed Central  PubMed  CAS  Google Scholar 

  8. Galton V.A., Ingbar S.H., Jimenez-Fonesca J., Hershman J.M. Alterations in thyroid hormone economy in patients with hydatidiform mole. J.Clin. Invest. 50:1345, 1971.

    PubMed Central  PubMed  CAS  Google Scholar 

  9. Webster J.B., Coupai J.J., Cushman Jr. P. Increased serum thyroine levels in euthyroid narcotic addicts. J. Clin. Endocrinol. Metab. 37: 928, 1973.

    PubMed  CAS  Google Scholar 

  10. Azizi F., Vagenakis A.G., Portnay G.I., Braverman L.E. Ingbar S.H. Thyroxine transport and metabolism in methadone and heroin addicts. Ann. Intern. Med. 80: 194, 1974.

    PubMed  CAS  Google Scholar 

  11. Oltman J.E., Friedman S. Protein bound iodine in patients receiving perphenazine. JAMA 185:726, 1963.

    PubMed  CAS  Google Scholar 

  12. Hollander C.S., Scott R.L., Tschudy D.P., Perlroth M., Maxman A., Sterling K. Increased protein bound iodine and thyroxine binding globulin in acute intermittent porphyria. N. Engl. J. Med., 227: 995, 1967.

    Google Scholar 

  13. Kydd D.M., Man E.B. Precipitable iodine of serum (SPI) in disorders of the liver. J.Clin. Invest., 30: 874, 1951.

    PubMed Central  PubMed  CAS  Google Scholar 

  14. Vannotti A., Béraud T. Functional relationships between the liver, the thyroxine binding protein of serum and the thyroid. J. Clin. Endocrinol. Metab. 19: 466, 1959.

    PubMed  CAS  Google Scholar 

  15. Schussler G.C., Schaffner F., Korn F. Increased serum thyroid hormone binding and decreased free hormone in chronic active liver disease. N. Engl. J. Med., 299: 510, 1978.

    PubMed  CAS  Google Scholar 

  16. Gardner D.F., Carithers Jr. R.L., Utiger R.D. Thyroid function tests in patients with acute and resolved hepatitis B virus infection. Ann. Intern. Med., 96: 450, 1982.

    PubMed  CAS  Google Scholar 

  17. Beierwalts W.H., Robbins J. Familial incrase in thyroxine binding sites in serum alpha globulin. J. Clin. Invest. 38: 1683, 1959.

    Google Scholar 

  18. Florsheim W.H., Dowling J.T., Meister L, Bodfish R.E. Familial elevation of serum thyroxine binding capacity. J. Clin. Endocrinol. Metab., 22: 735,1962.

    PubMed  CAS  Google Scholar 

  19. Jones J.E., Seal U.S. X-chromosome linked inheritance of elevated thyroxine-binding globulin. J. Clin. Endocrinol. Metab. 27:1521, 1967.

    PubMed  CAS  Google Scholar 

  20. Refetoff S., Fang V.S., Marshall J.S., Robin N.I. Metabolism of thyroxine binding globulin in man: abnormal rate of synthesis in inherited thyroxine-binding globulin deficiency and excess. J.Clin. Invest. 57: 485, 1976.

    PubMed Central  PubMed  CAS  Google Scholar 

  21. Fex G., Adielsson G., Mattson W. Oestrogen-like effects of tamoxifen on the concentration of proteins in plasma. Acta Endocrinol. (Kbh.) 97: 109, 1981.

    CAS  Google Scholar 

  22. Lever A., Bird D., Byfield P.G.H., Lalioz M.R.A., Webster A.D.B., Himsworth R.L. Increased serum concentration of T4-binding globulin in patients with hypogammaglobulinemia. Clin. Endocrinol. (Oxf.). 18: 195, 1983.

    PubMed  CAS  Google Scholar 

  23. Ingbar S.H., Braverman L.E., Dawber N.A., Lee G.Y. A new method for measuring the free thyroid hormone in human serum and an analysis of the factors that influence its concentration. J.Clin. Invest., 44: 1679, 1965.

    PubMed Central  PubMed  CAS  Google Scholar 

  24. Braverman L.E., Abreau C.M., Brock P., Kleinmann R., Fournier L, Odstrchel G., Schoemaker H.J.P. Measurement of serum free thyroxine by RIA in various, clinical states. J. Nucl. Med., 27:233, 1980.

    Google Scholar 

  25. Chopra I.J., Van Herle A.J., Chua Teco G.N., Nguyen A.H. Serum free thyroxine in thyroidal and nonthyroidal illnesses: a comparison of measurements by radioimmunoassay, equilibrium dialysis and free thyroxine index. J. Clin. Endocrinol. Metab., 51: 135, 1980.

    PubMed  CAS  Google Scholar 

  26. Glinoer D., McGuire R.A., Gershengorn M.C., Robbins J., Berman M. Effects of estrogen of thyroxine-binding globulin metabolism in rhesus monkeys. Endocrinology, 100:9: 1977.

    PubMed  CAS  Google Scholar 

  27. Henneman G., Docter R., Krenning E.P., Bos G., Otten M., Visser T.J. Raised total thyroxine and free thyroxine inex but normal free thyroxine: a serum abnormality due to inherited increased affinity of iodothyronine for serum binding protein. Lancet, 7:639, 1979.

    Google Scholar 

  28. Lee W.N.P., Golden M.P., Van Herle A.J., Lippe B.M., Kaplan S.A. Inherited abnormal thyroid hormone-binding protein causing selective increase of total serum thyroxine. J. Clin. Endocrinol. Metab. 49: 292, 1979.

    PubMed  CAS  Google Scholar 

  29. Stockigt J.R., Topliss D.J., Barlow, White E.L., Hurley D.M., Taft P. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. J. Clin. Endocrinol. Metab., 53: 353, 1981.

    PubMed  CAS  Google Scholar 

  30. Docter R., Bos G., Krenning E.P., Fekkes D., Visser T.J.. Hennemann G. Inherited thyroxine excess: a new serum abnormality due to an increased affinity for modified albumin. Clin. Endocrinol. (Oxf.). 15: 363, 1981.

    PubMed  CAS  Google Scholar 

  31. Ruiz M., Rajatanavin R., Young R.A., Taylor C., Brown R., Braverman L.E., Ingbar S.H. Familial dysalbuminemic hyperthyroxinemia, a syndrome that can be confused with thyrotoxicosis. N. Engl. J. Med., 306: 635, 1982.

    PubMed  CAS  Google Scholar 

  32. Borst G.C., Premachandra B.N., Burman K.D., Osburne R.C., Georges L.P., Johnsonbaugh R.E. Euthyroid familial hyperthyroxinemia due to abnormal thyroid hormone-binding protein. Am. J. Med., 73:283, 1982.

    PubMed  CAS  Google Scholar 

  33. Barlow J.W., Csicsmann J.M., White E.L, Funder J.W., Stockigt J.R. Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin. J. Clin. Endocrinol. Metab., 55: 244, 1982.

    PubMed  CAS  Google Scholar 

  34. Hennemann G., Bos G., Docter R. Familial inherited elevated serum thyroxine, caused by albumin with a higher affinity for thyroxine. Ann. Endocrinol. (Paris), 42: 34A, 1981 (abstract).

    Google Scholar 

  35. Ruiz M., Taylor C., Young R., Rajatanavin R., Braverman L.E., Ingbar S.H. Studies of the syndrome of familial euthyroid isolated hyperthyroxinemia (EIH). Proceeding of the 57th Annual Meeting of the American Thyroid Association, Minneapolis, 1981, p. T-3 (abstract).

    Google Scholar 

  36. White E.L., Barlow J.W., Burke C.W., Funder J.W., Stockigt J.R. A T4 loaded resin uptake system to detect familial euthyroid thyroxine excess. In: Stockigt J.R., Nagataki S. (Eds). Thyroid research VIII. Canberra, Australia, Australian Academy of Science, 1980, p. 513.

    Google Scholar 

  37. Stockigt J.R., Degaris M., Csicsmann J., Barlow J.W., White E.L, Hurley D.M. Limitation of a newfree thyroxine assay (Amerlex® Free T4). Clin. Endocrinol. (Oxf) 15: 313,1981.

    CAS  Google Scholar 

  38. Stockigt J.R., DeGaris M., Barlow J.W. “Unbound analogue” methods for free T4: a note of caution. N.Engl. J. Med., 307:126, 1982.

    PubMed  CAS  Google Scholar 

  39. Rajatanavin R., Fournier L, DeCosimo D., Abreau C., Braverman L.E. Elevated serum free thyroxine by thyroxine analog radioimmunoassays in euthyroid patients with familial dysalbuminemic hyperthyroxinemia. Ann. Intern. Med., 97: 865, 1982.

    PubMed  CAS  Google Scholar 

  40. Jacobsson B., Petterson T., Sandstedt B., Carlsfrom A. Prealbumin in the islets of Langerhans. IRCS Med., Sci, 7: 590, 1979.

    CAS  Google Scholar 

  41. Moses A.C., Lawlor J., Haddow J., Jackson I. Familial euthyroid hyperthyroxinemia resulting from increased thyroxine binding to thyroxine binding prealbumin. N. Engl. J. Med., 306: 966, 1982.

    PubMed  CAS  Google Scholar 

  42. Stockigt J.R., White E.L., Barlow J.W. Differences between familial hyperthyroxinemic syndrome. N. Engl. J. Med., 307: 824, 1982.

    PubMed  CAS  Google Scholar 

  43. Moses A.C., Lawlor J., Haddow J., Jackson I. Differences between familial hyperthyroxinemic syndrome. N.Engl. J. Med., 307: 825, 1982.

    Google Scholar 

  44. Robbins J., Rail J.E., Rawson R.W. An unusual instance of thyroxine-binding by human serum gamma globulin. J. Clin. Endocrinol. Metab., 16, 573, 1956.

    PubMed  CAS  Google Scholar 

  45. Premachandra B.N., Blumenthal H.T. Abnormal binding of thyroid hormone in sera from patients with Hashimoto’s disease. J. Clin. Endocrinol. Metab., 27: 931, 1967.

    PubMed  CAS  Google Scholar 

  46. Ikekubo K., Konishi J., Endo K., Nakajima K., Okuno T., Kasagi K., Mori T., Nagaka I., Torizuka K. Antityroxine and antitriiodothyronine antibodies in three cases of Hashimoto’s thyroiditis. Acta Endocrinol. (Kbh.). 89: 557,1978.

    CAS  Google Scholar 

  47. Staeheli V., Vallotton M.B., Burger A. Detection of human anti-thyroxine and anti-triiodothyronine antibodies in different thyroid conditions. J. Clin. Endocrinol. Metab., 41: 669, 1975.

    PubMed  CAS  Google Scholar 

  48. Trimarchi F., Benvenga S., Fenzi G., Mariotti S., Consolo F. Immunoglobulin binding of thyroid hormones in a case of Waldenstrom’s macroglobulinemia. J. Clin. Endocrinol. Metab., 54:1045, 1982.

    PubMed  CAS  Google Scholar 

  49. Wu S.Y., Green W. Triiodothyronine (T3) binding immunoglobulins in a euthyroid woman: Effects on measurement of T3 (RIA) and on T3 turnover. J. Clin. Endocrinol. Metab. 42: 642, 1976.

    PubMed  CAS  Google Scholar 

  50. Ginsberg J., Segal D., Erlich R.M., Walfish P.G. Inappropriate triiodothyronine (T3) and thyroxine (T4) radioimmunoassay levels secondary to circulating thyroid hormone autoantibodies. Clin. Endocrinol. (Oxf.) 8: 133,1978.

    CAS  Google Scholar 

  51. Konishi J., Iida Y., Kousaka T., Ikekubo K., Nakagawa T., Torizuka K. Effect of anti-thyroxine autoantibodies on radioimmunoassay of free thyroxin in serum. Clin. Chem. 28: 1389, 1982.

    PubMed  CAS  Google Scholar 

  52. Mullinger R.N., Walker G. Free thyroxine in thyroid disease. Clin. Chem. 28:1394, 1982.

    PubMed  CAS  Google Scholar 

  53. Karlsson F.A., Wibell L, Wide L. Hypothyroidism due to thyroid hormone binding antibodies. N. Engl. J. Med. 296: 1146,1977.

    PubMed  CAS  Google Scholar 

  54. Refetoff S., Dewind LT., De Groot L.J. Familial syndrome combining deaf-mutism, stippled epiphyses, goiter and abnormally high PBI: Possible target organ refractoriness to thyroid hormone. J. Clin. Endocrinol. Metab. 27: 279, 1967.

    PubMed  CAS  Google Scholar 

  55. Weintraub B.D., Gershengorn M.C., Kourides I.A., Fein H. Inappropriate secretion of thyroid stimulating hormone. Ann. Intern. Med., 95: 339, 1981.

    Google Scholar 

  56. Refetoff S., DeGroot L.J., Bernard B., Bewind L.T. Studies of a sibship with apparent hereditary resistance to intracellular action of thyroid hormone. Metabolism 21: 723, 1972.

    PubMed  CAS  Google Scholar 

  57. Brooks M.H., Barbato A.L., Collins S., Garbincus J., Neidballa R.G., Hoffman D. Familial thyroid hormone resistance. Am. J. Med., 77:414, 1981.

    Google Scholar 

  58. Bode H.H., Danon M., Weintraub B.D., Maloof F., Crawford J.D. Partial target organ resistance to thyroid hormone. J.Clin. Invest. 52: 776, 1973.

    PubMed Central  PubMed  CAS  Google Scholar 

  59. Lamberg B.A., Rosengard S., Leiwendahl K., Saarien P., Evered D.C. Familial partial peripheral resistance to thyroid hormones. Acta Endocrinol (Kbh.). 87: 303, 1978.

    CAS  Google Scholar 

  60. Liewendahl K. Triiodothyronine binding to lymphocytes from euthyroid subjects and a patient with peripheral resistance to thyroid hormone. Acta Endocrinol (Kbh.). 83: 64, 1976.

    CAS  Google Scholar 

  61. Liewendahl K., Rosengard S., Lamberg B.A. Nuclear binding of triiodothyronine and thyroxine in lymphocytes from subjects with hyperthyroidism, hypothyroidism and resistance to thyroid hormones. Clin. Chem. Acta. 83:41, 1978.

    CAS  Google Scholar 

  62. Bemal J., Refetoff S., DeGroot L.J. Abnormality of triiodothyronine binding to lymphocyte and fibroblast nuclei from a patient with peripheral tissue reistance to thyroid hormone action. J. Clin. Endocrinol. Metab., 47: 1266, 1978.

    Google Scholar 

  63. Kaplowitz P.B., D’Ercole J.A, Utiger R.D. Peripheral resistance to thyroid hormone in an infant. J. Clin. Endocrinol Metab., 53: 958, 1981.

    PubMed  CAS  Google Scholar 

  64. Chait A., Kanter R., Green W., Kenny M. Defective thyroid hormone action in fibroblasts cultured from subjects with the syndrome of resistance to thyroid hormones. J. Clin. Endocrinol Metab., 54: 767, 1982.

    PubMed  CAS  Google Scholar 

  65. Gershengorn M.C. Weintraub B.D. Thyrotropin-induced hyperthyroidism caused by selective pituitary resistance to thyroid hormone: A new syndrome of “inappropriate secretion of TSH”. J. Clin. Invest. 56: 633, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  66. Kaplan M.M., Swartz S.L, Larsen P.R. Partial peripheral resistance to thyroid hormone. Am. J. Med., 50: 1115, 1981.

    Google Scholar 

  67. Wartofsky L, Berman K.D. Alterations in thyroid function in patients with systemic illness: The “euthyroid sick syndrome”. Endocrin. Rev. 3: 164, 1982.

    CAS  Google Scholar 

  68. Kaptein L.M., Maclntyre S.S., Weiner J.M., Spencer C.A., Nicoloff J.T. Free thyroxine estimates in nonthyroidal illness: Comparison of eight methods. J. Clin. Endocrinol Metab., 52: 1073, 1981.

    PubMed  CAS  Google Scholar 

  69. Chopra I.J., Chua Teco G.N., Nguyen A., Solomon D. In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J. Clin. Endocrinol. Metab., 48: 63, 1979.

    Google Scholar 

  70. Oppenheimer J.H., Schwartz H.L., Mariash C.N., Kaiser F.E. Evidence for a factor in the sera of patients with nonthy-roidal disease which inhibits iodothyronine binding by solid matrices, serum proteins and rat hepatocyte. J. Clin. Endocrinol. Metab., 54: 757, 1982.

    PubMed  CAS  Google Scholar 

  71. Chopra I.J., Solomon D.H., Chua Teco G.N., Eisenberg J.B. An inhibitor of the binding of thyroid hormones to serum proteins is present in extrathyroidal tissues. Science, 275:407, 1982.

    Google Scholar 

  72. Chopra I.J., Solomon D.H., Hepner G.W., Morgenstein A.A. Misleading low free thyroxine index and usefulness of reverse triiodothyronine measurement in nonthyroidal illnesses. Ann. Intern. Med., 90: 905, 1979.

    PubMed  CAS  Google Scholar 

  73. Bacci V., Schussler G.C., Kaplan T.B. The ralationship between serum triodothyronine and thyrotropin during systemic illness. J. Clin. Endocrinol. Metab., 54: 1229, 1972.

    Google Scholar 

  74. Gavin L.A., Rosenthal M., Cavalieri R.R. The diagnostic dilemma of isolated hyperthyroxinemia in acute illness. JAMA 242: 251, 1979.

    PubMed  CAS  Google Scholar 

  75. Burrows A.W., Shakesper R.A., Hesch R.D., Cooper E., Aicken C.M., Burke C.W. Thyroid hormones in elderly sick: “T4 euthyroidism”. Br. Med. J. 4: 437, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  76. Britton K.E., Quinn V., Ellis S.M., Miralles J.M., Quinn V., Cayley A.C.D., Brown B., Ekins R.P. Is “T4 a normal biochemical finding in elderly women? Lancet 2: 141, 1975.

    PubMed  CAS  Google Scholar 

  77. Gooch B.R., Isley W.L, Utiger R.D. Abnormalities in thyroid function tests in patients admitted to a medical service. Arch. Intern. Med. 142: 1801, 1982.

    PubMed  CAS  Google Scholar 

  78. Turner T.G., Brownlie B.E.W., Sadder W.A. Does T4 toxicosis exist? Lancet 7: 407, 1975.

    Google Scholar 

  79. Caplan R.H., Pagliara A.S., Wickus G. Thyroxine thyrotoxicosis a common variant of hyperthyroidism. JAMA 17: 1934, 1980.

    Google Scholar 

  80. Birkhauser M., Busset R., Burer T., Burger A. Diagnosis of hyperthyroidism when serum thyroxine alone is raised. Lancet 2: 53, 1977.

    PubMed  CAS  Google Scholar 

  81. Engler D., Donaldson E.B., Stockigt J.R., Taft P. Hyperthyroidism without triiodothyronine excess: An effect of severe non-thyroidal illness. J. Clin. Endocrinol. Metab. 46: 77, 1978.

    PubMed  CAS  Google Scholar 

  82. Maturlo S.J., Rosenbaum R.L, Pan C., Surks MI. Variable thyrotropin response to thyrotropin releasing hormone after small decrease in plasma free thyroid hormone concentrations in patients with nonthyroidal disease. J.Clin. Invest., 66:451, 1980.

    PubMed Central  PubMed  CAS  Google Scholar 

  83. Whybrow P.C., Prange A.J., Treadway C.K. Mental changes accompanying thyroid gland dysfunction. Arch. Gen. Psych., 20: 48, 1969.

    CAS  Google Scholar 

  84. McLarty D.G., Ratcliffe W.A., Ratcliffe J.G., Shimmins J.G., Goldberg A. A study of thyroid function in psychiatric in-patients. Br. J. Psych. 733:211, 1978.

    Google Scholar 

  85. Whybrow P.C., Coppen A., Prange A.J., Noguerra R., Bailey J.E. Thyroid function and the response to liothyronine in depression. Arch. Gen. Psych. 26: 242, 1972.

    CAS  Google Scholar 

  86. Goldberg I.J.L, Lawton K., Ridges A.P. The effect of depression and its treatment on serum thyroxine. Post Grad. Med. J. 53: 211, 1977.

    CAS  Google Scholar 

  87. Kirkegaard C., Faber J. Altered serum levels of thyroxine, tri-iodothyronines and diidothyronines in endogenous depression. Acta Endocrinol (Kbh.). 86: 199, 1981.

    Google Scholar 

  88. Pecknold J.C., Ban T.A., Lehmann H.E., Nair N.P.V., Orbach L. Thyrotropin releasing hormone in depression: Clinical and endocrinological findings. Psycho Pharmac. Bull., 14: 44, 1976.

    Google Scholar 

  89. Cohen L.K., Swigar M.E. Thyroid function screening in psychiatric patients. JAMA, 242: 254, 1979.

    PubMed  CAS  Google Scholar 

  90. Spratt D.I., Pont A., Miller M.B., McDougall I.R., Bayer M.F., McLaughlin W.T. Hyperthyroxinemia in patients with acute psychiatric disorders. Am. J. Med., 73:41, 1982.

    PubMed  CAS  Google Scholar 

  91. Brunn T., Kristoffersen K. Thyroid function during pregnancy, with special reference to hydatidiform mole and hyperemesis. Acta Endocrinol. (Kbh.), 88: 383, 1978.

    Google Scholar 

  92. Bouillon R., Naesens M., Van Assche Thyroid function in patients with hyperemesis gravidarum. Am. J. Obstet. Gynectol., 143: 922, 1982.

    CAS  Google Scholar 

  93. Kenimer J.G., Hershman J.M., Higgens P.M. The thyrotropin in hydatidiform moles in human chorionic gonadotropin. J. Clin. Endocrinol. Metab., 40: 482, 1975.

    PubMed  CAS  Google Scholar 

  94. Fairweather D.V.I. Nausea and vomitting in pregnancy. Am. J. Obstet. Gynecol. 102: 135,1968.

    PubMed  CAS  Google Scholar 

  95. Cavalieri R.R., Pitt-Rivers R. The effects of drugs on the distribution and metabolism of thyroid hormones. Pharm. Rev., 32: 55, 1981.

    Google Scholar 

  96. Bürgi H., Wimpheimer C., Burger A., Zaunbauer W., Rosier H., Lemarchand-Béraud T. Changes of circulatory thyroxine, triiodothyronine and reverse triiodothyronine after radiographic contrast agents. J. Clin. Endocrinol., Metab., 43: 1203, 1976.

    Google Scholar 

  97. Kleinmann R.E., Vagenakis A.G., Braverman L.E. The effect of iopanoic acid on the regulation of thyrotropin secretion in euthyroid subjects. J. Clin. Endocrinol. Metab. 51: 399, 1980.

    PubMed  CAS  Google Scholar 

  98. Larsen P.R., Dick T.E., Markovitz B.P., Kaplan M.M., Gard T.G. Inhibition of intrapituitary thyroxine to 3,5, 3′-triiodo-thyronine conversion prevents the acute suppression of thyrotropin released by thyroxine in hypothyroid rats. J.Clin. Invest. 64:117, 1979.

    PubMed Central  PubMed  CAS  Google Scholar 

  99. Obregon M.J., Pascual A., Mallol J., Morreale de Escobar G., Escobar Del Rey F. Evidence against a major role of L-thyroxine at the pituitary level: Studies in rats treated with iopanoic acid (Telepaque). Endocrinology 106: 1827, 1980.

    PubMed  CAS  Google Scholar 

  100. Felicetta J.V., Green W.L, Nelp W.B. Inhibition of hepatic binding of thyroxine by cholecystographic agents J.Clin. Invest., 65:1032, 1980.

    PubMed Central  PubMed  CAS  Google Scholar 

  101. Larsen P.R. Thyroid-pituitary interaction: Feedback regulation of thyrotropin secretion by thyroid hormone. N.Engl. J. Med. 306: 23, 1982.

    PubMed  CAS  Google Scholar 

  102. Kleinmann R.E., Sternthal E., Starobin O., Braverman LE. Cardiac catheterization dye does not affect serum thyroid hormone concentrations or TSH secretion. Cath. Card. Diag. 8:261, 1982.

    CAS  Google Scholar 

  103. Fairhurst B.J., Nagui N. Hyperthyroidism after cholecystography. Br. Med. J., 3:630, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  104. Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Béraud T., Vallotton M.B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin and thyrotropin. A drug influencing peripheral metabolism of thyroid hormone. J. Clin. Invest., 58: 255, 1976.

    PubMed Central  PubMed  CAS  Google Scholar 

  105. Melmed S., Nademanee K., Reed A.W., Hendrickson J.A., Singh B.N., Hershman J.M. Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration. J. Clin. Endocrinol. Metab., 53: 997, 1981.

    PubMed  CAS  Google Scholar 

  106. Jonckheer M.H., Blockx P., Kaivers R., Wyffels G. Hyperthyroidism as a possible complication of the treatment of ischemic heart disease with amiodarone. Acta Cardiol (Brux). 28: 192, 1973.

    CAS  Google Scholar 

  107. Jonckheer M.H., Blockx P., Broeckaer I., Cornette C., Beckers C. “Low T3, syndrome” in patients chronically treated with an iodine-containing drug, amiodarone. Clin. Endocrinol. (Oxf)., 9: 27, 1978.

    PubMed  CAS  Google Scholar 

  108. Bekaert J., Solvay H., Van Schepdael J. Etude de l’effect de l’amiodarone sur la fonction thyroidienne. Coeur Med. Interne, 18: 241, 1979.

    PubMed  CAS  Google Scholar 

  109. Damgaard Anderson E. Long-term antiarrhythmic therapy with amiodarone. High prevalence of thyrotoxicosis (11%). Eur. Hearth J. 2(Suppl A): 199, 1981.

    Google Scholar 

  110. Borghi A., Bassi F., Gheri R.G. Endocrinological aspects of long-term amiodarone treatment in arrhythmic patients. In: Abstract Book, Le nuove frontière délie aritmie (seminar), Marilleva (Italy), 1982, p. 74.

    Google Scholar 

  111. Chevigne-Brancard M., Vandalem J.L. Thyroid function during and after amiodarone therapy. Proceeding of the 64th Annual Meeting of the Endocrine Society, San Francisco, 1982, p. 111 (abstract).

    Google Scholar 

  112. Jaggarao N.S.V., Sheldon J., Grundy E.N., Vincent R., Chamberlain D.A. The effects of amiodarone on thyroid function. Post Grad. Med. J., 58:693, 1982.

    CAS  Google Scholar 

  113. Jonckheer M.H. Amiodarone and thyroid gland — a review. Acta Cardiol. (Brux). 36: 199, 1981.

    CAS  Google Scholar 

  114. Morley J.E., Shafer R.B., Elson M.K., Flag M.L., Raleigh M.J., Brammer G., Yuwiler A., Hershman J. Amphetamine-induced hyperthyroxinemia. Ann. Intern. Med., 93:707, 1980.

    PubMed  CAS  Google Scholar 

  115. Hollander C.S., Scott R.L., Burgess J.A., Rabinowitz D., Mérimée T.J., Oppenheimer J.H. Free fatty acids: A possible regulation of free thyroid hormone levels in man. J. Clin. Endocrinol. Metab., 27: 1219, 1967.

    PubMed  CAS  Google Scholar 

  116. Schatz D.L., Sheppard R.H., Steiner G., Chandarlapaty C.S., De Vebur G.A. Influence of heparin on serum free thyroxine. J. Clin. Endocrinol. Metab., 29: 1015, 1969.

    PubMed  CAS  Google Scholar 

  117. Hershman J.M., Jones C.M., Bailey A.L. Reciprocal changes in serum thyrotropin and free thyroxine produced by heparin J. Clin. Endocrinol Metab., 34: 574, 1972.

    Google Scholar 

  118. Schwartz H.I., Schadlow A.R., Faierman D., Surks M.I., Oppenheimer J.H. Heparin administration appears to decrease cellular binding of thyroxine. J. Clin. Endocrinol. Metab., 36: 598, 1973.

    PubMed  CAS  Google Scholar 

  119. Boss M., Kingstone D., Chang M.K., Varghese Z. Contradictory findings in the measurements of free thyroxine after administration of heparin. Clin. Chem., 28: 1238, 1982.

    PubMed  CAS  Google Scholar 

  120. Lundberg P.A., Jagenburg K., Lindstedt G., Nystrom E. Heparin in vivo effect on free thyroxine. Clin. Chem., 28: 1241, 1982.

    PubMed  CAS  Google Scholar 

  121. Shanks R.B., Hadden D.R., Lowe D.C., McDermitt D.G., Montgomery D.A.D. Control trial of propranolol in thyrotoxicosis. Lancet, 7:993, 1969.

    Google Scholar 

  122. Harrower A.D.B, Fyffe J.A., Horn D.B., Strong J.A. Thyroxine and triiodothyronine levels in hyperthyroid patients during tratment with propranolol. Clin. Endocrinol. (Oxf.) 7: 41, 1977.

    CAS  Google Scholar 

  123. Verhoeven R.P., Visser T.J., Docter R., Hennemann G., Schalekamp M.A.D.H. Plasma thyroxine, 3,3′, 5-triiodothyronine and 3,3′, 5-triiodo-thyronine during β-adrenergic blockade in hyperthyroidism. J. Clin. Endocrinol. Metab. 44: 1002, 1977.

    PubMed  CAS  Google Scholar 

  124. Wiersinga W.M., Touber J.L. The influence of β-adrenoreceptor blocking agents on plasma thyroxine and triiodothyronine. J. Clin. Endocrinol. Metab., 45: 293, 1977.

    PubMed  CAS  Google Scholar 

  125. Cooper D.S., Daniels G.H., Ladenson P.W., Ridgway E.C. Hyperthyroxinemia in patients treated with high-dose propranolol. Am. J. Med., 73:867, 1982.

    PubMed  CAS  Google Scholar 

  126. Heyma P., Larkins R.G., Campbell D.G. Inhibition by propranolol of 3,5,3′ triiodothyroxine formation from thyroxine in isolated rat renal tubules: An effect independent of β-adrenergic blockade. Endocrinology, 106: 1437, 1980.

    PubMed  CAS  Google Scholar 

  127. Perrild H., Molholm Hansen J., Skovsted L, Korsgaard Christensen L. Different effects of propranolol, alprenolol, Sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism. Clin. Endocrinol. (Oxf.) 18: 139, 1983.

    CAS  Google Scholar 

  128. Braverman L.E., Vagenakis A.G., Downs P., Foster A.E., Sterling K., Ingbar S.H. Effects of replacement doses of sodium L-thyroxine on the peripheral metabolism of thyroxine and triiodothyronine in man. J. Clin. Invest., 52: 1010, 1973.

    PubMed Central  PubMed  CAS  Google Scholar 

  129. Stock J.M., Surks M.I., Oppenheimer J.H. Replacement dosage of L-thyroxine in hypothyroidism: a re-evaluation. N.Engl. J. Med., 290: 529, 1974.

    PubMed  CAS  Google Scholar 

  130. Saberi M., Utiger R.D. Serum thyroid hormone and thyrotropin concentrations during thyroxine and triiodothyronine therapy. J. Clin. Endocrinol. Metab., 39: 923, 1974.

    PubMed  CAS  Google Scholar 

  131. Kahn A. Serum thyroxine levels in patients reveiving L-thyroxine suppression or replacement therapy. Can. Med. Assoc. J. 109: 279, 1973.

    PubMed Central  PubMed  CAS  Google Scholar 

  132. Wong M.M., Volpè R. What is the best for monitoring level of thyroxine therapy? Can. Med. Assoc. J. 124: 1181, 1981.

    PubMed Central  PubMed  CAS  Google Scholar 

  133. Ingbar J.C., Borges M., Iflash S., Kleinmann R.E., Braverman L.E., Ingbar S.H. Elevated serum thyroxine concentration in patients receiving “replacement” doses of levothyroxine. J. Endocrinol. Invest. 5: 77, 1982.

    PubMed  CAS  Google Scholar 

  134. Lo Presti J.S., Warren D.W., Kaptein E.M., Croyson M.J., Nicoloff J.T. Urinary immunoprecipitation method for estimation of thyroxine to triiodothyronine conversion in altered thyroid states. J. Clin. Endocrinol. Metab. 55: 666, 1982.

    CAS  Google Scholar 

  135. Brown M.E., Refetoff S. Transient elevation of serum thyroid hormone concentration after initiation of replacement therapy in myxedema. Ann. Intern. Med., 92: 491, 1980.

    PubMed  CAS  Google Scholar 

  136. Greene R., Ferran H.E. The physiological activity of D-thyroxine. Br. Med. J. 2: 1057, 1958.

    PubMed Central  PubMed  CAS  Google Scholar 

  137. Oliver M.F., Boyd G.S. Reduction of serum cholesterol by dextro thyroxine in men with coronary heart disease. Lancet, 7:783, 1961.

    Google Scholar 

  138. Gorman C.A., Jiang N.S., Ellefson R.D., Elveback L.R. Comparative effectiveness of dextrothyroxine and levothyroxine in correcting hypothyroidism and lowering blood lipid levels in hypothyroid patients. J. Clin. Endocrinol. Metab., 49: 1, 1979.

    PubMed  CAS  Google Scholar 

  139. Bantle J.P., Oppenheimer J.H., Schwartz H.L., Hunninghake D.B., Propbsfield J.L., Hanson R.F. TSH response to TRH in euthyroid, hypercholestero-lemic patients treated with graded dose of dextrothyroxine. Metabolism., 30:63, 1981.

    PubMed  CAS  Google Scholar 

  140. Leb G., Lankmayer F.P., Goebel R., Pristautz H., Nachtmann F., Knapp G. Stereospecific determination of D-thyroxin and L-thyroxin in serum. Klin. Wochenschr. 59: 861, 1981.

    PubMed  CAS  Google Scholar 

  141. Surks M.I. Elevated PBI, free thyroxine, and plasma protein concentration in man at high altitude. J. Appl., Physiol., 27: 1185, 1966.

    Google Scholar 

  142. Kotchen T.A., Mongey E.H., Hogan K.P., Boyd III A.E., Pennington L.L., Mason J.W. Thyroid response to simulated altitude. J. Appl. Physiol. 34: 165, 1973.

    PubMed  CAS  Google Scholar 

  143. Rastogi G.K., Malhotra M.S., Srivastava M.C., Sawhney R.C., Dua G.L., Sridharan K., Hoon R.S., Singh I. Study of the pituitary-thyrodi functions at high altitude in man. J. Clin. Endocrinol. Metab., 44: 447, 1977.

    PubMed  CAS  Google Scholar 

  144. Mordes J.P., Blume F.D., Boyer S., Zheng M., Braverman L.E. Pituitary-thyroid physiology on Mt. Everest. Proceedings of the 58th Annual Meeting of the American Thyroid Association, Quebec City, 1982, p. 7 (abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology and Metabolism, Department of Medicine, University of Massachusetts Medical School, 55 Lake Avenue North Worcester, Worcester, Massachusetts, 01605, USA

    R. Rajatanavin &  L. E. Braverman

Authors
  1. R. Rajatanavin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. E. Braverman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rajatanavin, R., Braverman, L.E. Euthyroid hyperthyroxinemia. J Endocrinol Invest 6, 493–505 (1983). https://doi.org/10.1007/BF03348351

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348351

Key-words

Search

Navigation